Yan Xiaojun, Duan Wanxin, Wang Xiangdong
Department of Marine Biotechnology, School of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, China.
Department of Respiratory Critical Care Medicine, Zhongshan Hospital, Fudan University Shanghai Medical College, Shanghai, China.
Clin Transl Med. 2025 Apr;15(4):e70303. doi: 10.1002/ctm2.70303.
Marine biomedicine is an important field in oceanology and bio-ecosystem and has evolved significantly alongside advances in biotechnology and growing understanding of marine life. In this perspective, we propose a refined concept of clinical marine biomedicine, with a clear mission to establish an emerging discipline that bridges marine biomedicine and clinical practice. The exploration of marine-origin sources should be emphasised, with a strong focus on the identification, validation and development of human disease-specific diagnostics and target-oriented pharmaceutics. The perspective headlines some of critical components, including marine-oriented human evolution and development, humanised marine-based models, biomarker innovation and validation, marine microbiomes and metabolites, and target nutrition and therapy. We envision that clinical marine biomedicine will become a crucial pillar clinical molecular medicine, contributing to the improvement of human health and the prognosis of patient.
海洋生物医学是海洋学和生物生态系统中的一个重要领域,随着生物技术的进步以及对海洋生物认识的不断加深而有了显著发展。从这个角度来看,我们提出了临床海洋生物医学的细化概念,其明确使命是建立一门连接海洋生物医学与临床实践的新兴学科。应强调对海洋来源的探索,重点是针对人类疾病的诊断方法和靶向药物的识别、验证与开发。本文阐述了一些关键要素,包括海洋导向的人类进化与发育、人源化海洋模型、生物标志物的创新与验证、海洋微生物群和代谢产物,以及靶向营养与治疗。我们设想,临床海洋生物医学将成为临床分子医学的关键支柱,有助于改善人类健康和患者预后。